Venous thromboembolic disease in the pediatric intensive care unit

Current Opinion in Pediatrics

Volumn 11, Issue 3, 1999, Pages 213-217

  Donnelly, Kathleen M ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

CENTRAL VENOUS CATHETER; HUMAN; INTENSIVE CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOEMBOLISM; VEIN THROMBOSIS;

CANADA; CHILD; HUMANS; INCIDENCE; INTENSIVE CARE UNITS, PEDIATRIC; PRACTICE GUIDELINES; RISK FACTORS; THROMBOEMBOLISM; UNITED STATES; VENOUS THROMBOSIS;

EID: 0033013975     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199906000-00007     Document Type: Review

References (36)

1. 1 Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et al.: Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994. 83:1251-1257.
2. 2 Schmidt B, Andrew M: Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995. 96:939-943.
3. 3 Massicotte MP, Dix D, Monagle P, Adams M, Andrew M: Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998, 133:770-776. This excellent study describes 244 children with CVC-related DVT and provides the best current data on the outcome and associated complications.
4. 4 Turpie AG: Successors to heparin: new antithrombotic agents. Am Heart J 1997, 134:S71-S77.
5. 5 Rohrer MJ, Cutler BS, MacDougall E, Hermann JB, Anderson FA Jr, Wheeler HB: A prospective study of the incidence of deep venous thrombosis in hospitalized children. J Vase Surg 1996, 24:46-49.
6. 6 DeAngelis GA, Mcllhenny J. Willson DF, Vittone S, Dwyer SJ, Gibson JC, Alford BA: Prevalence of deep venous thrombosis in the lower extremities of children in the Intensive care unit. Pediatr Radiol 1996, 26:821-824.
7. 7 Shefler A, Gillis J, Lam A, O'Connell AJ, Schell D; Inferior vena cava thrombosis as a complication of femoral vein catheterisation. Arch Dis Child 1995, 72:343-345.
8. 8 David M, Andrew M: Venous thromboembolism complications in children: a critical review of the literature. J Pediatr 1993, 123:337-346.
9. 9 Uttenreuther-Rscher MM, Vetter B, Hellmann C, Otting U, Ziemer S, Hausdorf G, et al.: Paedtatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr 1997, 156:277-281.
10. 10 Michelson AD, Bovill E, Andrew M: Antithrombotic therapy in children. Chest 1995, 108(suppl):506-522.
11. 11 Eskandari MK, Bontempo FA, Hassett AC, Faruki H, Makaroun MS: Arterial thromboembolic events in patients with the factor V Leiden mutation. Am J Surg 1998, 176:122-125.
12. 12 Larsen TB, Lassen JF, Brandslund I, Byriel L, Petersen GB, Norgaard-Pedersen B: The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns. Thromb Res 1998, 89:211-215.
13. 13 Ridker PM, Miletich JP, Hennekens CH, Buring JE: Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. JAMA 1997, 277:1305-1307.
14. 14 Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA: Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998, 133:777-781. This study examined the prevalence of inherited prothrombotic defects and antiphospholipid antibodies in 85 neonates and children with thromboembolic disease.
15. 15 Nowak-Gottl U, Koch HG, Ashka I, Kohlhase B, Vielhaber H, Kurlemann G, et al.: Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996, 92:992-998.
16. 16 Manco-Johnson MJ: Disorders of hemostasis in childhood: risk factors for venous thromboembolism. Thromb Haemost 1997, 78:710-714.
17. 17 Toumi NH, Khaldi F, Ben Becheur S, Hammou A, Bouttiere B, Sampol J, Boukef K: Thrombosis in congenital deficiencies of AT III, protein C or protein S: a study of 44 children. Hematol Cell Ther 1997, 39:295-299.
18. 18 Nuss R, Hays T, Chudgar U, Manco-Johnson M: Antiphospholipid antibodies and coagulation regulatory protein abnormalities in children with pulmonary emboli, J Vasc Surg 1998, 28:250-259.
19. 19 Nuss R, Hays T. Marico-Johnson M: Childhood thrombosis. Pediatrics 1995, 96:291-294.
20. 20210→A transition is a risk factor for cerebral venous thrombosis. Stroke 1998, 29:1765-1769.
21. 21 Biousse V, Conard J, Brouzes C, Horellou MH, Ameri A, Bousser MG: Frequency of the 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis. Stroke 1998, 29:1398-1400.
22. 20210 mutation. Thromb Haemost 1998, 79:907-911.
23. 23 Taylor PR: Deep venous thrombosis in an injured child with an underlying thrombophilia [case report]. Injury 1997, 28:699-700.
24. 24 Andrew M, Michelson AD, Bovill E, Leaker M, Massicotte MP: Guidelines for antithrombotic therapy in pediatric patients. Am J Respir Crit Care Med 1998, 158:470-476. This superb and extensive review includes current recommendations for treatment and prophylaxis supported by available evidence.
25. 25 Uderzo C, Faccini P, Rovelli A, Arosio M, Marchi PF, Riva A, et al.: Pulmonary thromboembolism in childhood leukemia: 8 years' experience in a pediatric hematology center. J Clin Oncol 1995, 13:2805-2812.
26. 26 Andrew M, Brooker LA: Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996, 10:88-99.
27. 27 Andrew M, Marzinotto V, Pencharz P, Zlotkin S, Burrows P, Ingram J, et al.: A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr 1995, 126:358-363.
28. 28 David M, Manco-Johnson N, Andrew M, on behalf of the Subcommittee on Perinatal Haemostasis of the Scientific and Standardization Committee of the ISTH: Diagnosis and treatment of venous thromboembolism in children and adolescents. Thromb Haemost 1995, 74:791-792.
29. 29 American College of Chest Physicians Consensus Committee on Pulmonary Embolism: Opinions regarding the diagnosis and management of venous thromboembolic disease. Chest 1998, 113:499-504.
30. 30 Derish MT, Smith DW, Frankel LR: Venous catheter thrombus formation and pulmonary embolism in children. Pediatr Pulmonol 1995, 20:349-354.
31. 31 Taylor A, Beveridge R, Barry M, Beique M, Dowhan D, Holroyd B, et al.: Guidelines for the use of imaging techniques for the investigation of venous thromboembolic disease. J Emerg Med 1998, 16:663-668. This comprehensive review makes eight specific recommendations on the diagnosis of VTE and reviews the evidence to support the recommendations.
32. 32 Massicotte P, Adams M, Marzinotto V, Brooker LA: Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996, 128:313-318.
33. 33 Leaker M, Massicotte MP, Brooker LA, Andrew M: Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost 1996, 76:132-134.
34. 34 Zenz W, Arlt F, Sodia S: Thrombolytic therapy in pediatric patients. Thromb Haemost 1997, 77:1215-1224.
35. 35 Petaja J, Lundstrom U, Sairanen H, Marttinen E, Griffin JH: Central venous thrombosis after cardiac operations in children. J Thorac Cardiovasc Surg 1996, 112:883-889.
36. 36 Randolph AG, Cook DJ, Gonzales CA, Andrew M: Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 1998, 113:165-171.